United States · Bill · S
S. 2328 (108th)
Pharmaceutical Market Access and Drug Safety Act of 2004
Introduced
21 April 2004
Last action
—
Status
Committee on the Judiciary. Hearings held.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Pharmaceutical Market Access and Drug Safety Act of 2004 - Amends the Federal Food, Drug, and Cosmetic Act to revise provisions governing the importation of prescription drugs. Requires the Secretary of Health and Human Services to promulgate regulations allowing the importation of prescription drugs by registered exporters or registered importers from Canada within 90 days of passage of this Act and from Australia, European Union countries, Japan, New Zealand, or Switzerland within one year. Provides for inspection, tracking of drugs, and registration and inspection fees for registered importers and exporters. Requires manufacturers to: (1) submit a statement to the Secretary explaining each difference between a drug approved and distributed in the United States and a related drug distributed in a foreign country; and (2) submit an application to the Food and Drug Administration (FDA) for approval of a related drug that is distributed in a foreign country if there is no comparable drug already approved in at least half of the permitted countries that can be imported to the United States. Allows for the immediate importation of prescription drugs for personal use from licensed Canadian pharmacies. Amends the Clayton Act to prohibit drug manufacturers from preventing importation by engaging in behavior such as charging higher prices or limiting supplies to registered exporters and importers or changing the form of the drug for such purpose. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary of Homeland Security to refuse admission of drugs that violate importation provisions. Allows the destruction of certain violative shipments. Amends the Controlled Substances Act to repeal the exemption that permitted individuals to import controlled substances for personal medical use.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 21 April 2004
Introduced in Senate (PDF)
Introduced in Senate · EN · 21 April 2004
Introduced in Senate
summary · EN · 21 April 2004
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/senate-bill/2328
- Open data entity: https://api.congress.gov/v3/bill/108/s/2328